The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biophysical Journal

• Publication date

  2008-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1529/biophysj.108.134429PMID 18599641PMCID PMC2547438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment.

  2008cited by this paper
• Structural features of the Cu(II) complex with the rat Abeta(1-28) fragment.

  2008cited by this paper
• Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.

  2008cited by this paper
• Metals in proteins: correlation between the metal-ion type, coordination number and the amino-acid residues involved in the coordination.

  2008cited by this paper
• Identifying the Minimal Copper- and Zinc-binding Site Sequence in Amyloid-β Peptides*

  2008cited by this paper
• Neurotoxicity in Alzheimer’s disease: is covalently crosslinked Aβ responsible?

  2008cited by this paper
• Solution [Cu(amm)]2+ is a strongly solvated square pyramid: a full account of the copper K-edge XAS spectrum within single-electron theory.

  2008cited by this paper
• X-ray absorption and diffraction studies of the metal binding sites in amyloid beta-peptide.

  2008cited by this paper
• Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.

  2008cited by this paper
• Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible?

  2008cited by this paper
• X-ray absorption and diffraction studies of the metal binding sites in amyloid β-peptide

  2008cited by this paper
• Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease

  2008cited by this paper
• Different Hydration Changes Accompanying Copper and Zinc Binding to Amyloid β‐Peptide: Water Contribution to Metal Binding

  2008cited by this paper
• Attenuated amyloid-&bgr; aggregation and neurotoxicity owing to methionine oxidation

  2007cited by this paper
• The redox chemistry of the Alzheimer's disease amyloid β peptide

  2007cited by this paper
• Redox Chemistry of Copper–Amyloid‐β: The Generation of Hydroxyl Radical in the Presence of Ascorbate is Linked to Redox‐Potentials and Aggregation State

  2007cited by this paper
• EXAFS Energy Shift and Structural Parameters

  2007cited by this paper
• The redox chemistry of the Alzheimer's disease amyloid beta peptide.

  2007cited by this paper
• Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance†

  2007cited by this paper
• Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.

  2007cited by this paper
• High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide

  2007cited by this paper
• High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.

  2007cited by this paper
• Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.

  2007cited by this paper
• Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro Aging*

  2006cited by this paper
• Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

  2006cited by this paper
• Probing the influence of X-rays on aqueous copper solutions using time-resolved in situ combined video/X-ray absorption near-edge/ultraviolet-visible spectroscopy.

  2006cited by this paper
• Characterization of copper binding to the peptide amyloid‐β(1–16) associated with Alzheimer's disease

  2006cited by this paper
• Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

  2006cited by this paper
• Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge*

  2006cited by this paper
• The hydration of Cu2+: Can the Jahn-Teller effect be detected in liquid solution?

  2006cited by this paper
• Metal binding in amyloid β-peptides shows intra- and inter-peptide coordination modes

  2006cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.

  2005cited by this paper
• ATHENA, ARTEMIS, HEPHAESTUS: data analysis for X-ray absorption spectroscopy using IFEFFIT.

  2005cited by this paper
• Synchrotron radiation effects on catalytic systems as probed with a combined in-situ UV-vis/XAFS spectroscopic setup.

  2005cited by this paper
• Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity*

  2005cited by this paper
• Three-dimensional structure determination using multiple-scattering analysis of XAFS: applications to metalloproteins and coordination chemistry

  2005cited by this paper
• Ab initio x-ray absorption study of copper K-edge XANES spectra in Cu(II) compounds

  2005cited by this paper
• Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.

  2005cited by this paper
• Amyloid-β Binds Cu2+ in a Mononuclear Metal Ion Binding Site

  2004cited by this paper
• Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.

  2004cited by this paper
• Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution*

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Electron transfer by copper centers.

  2004cited by this paper
• Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques.

  2004cited by this paper
• Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation*

  2003cited by this paper
• Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study.

  2003cited by this paper
• Metal Ions, pH, and Cholesterol Regulate the Interactions of Alzheimer's Disease Amyloid-β Peptide with Membrane Lipid*

  2003cited by this paper
• Group-fitted ab initio single- and multiple-scattering EXAFS Debye-Waller factors

  2002cited by this paper
• Modern aspects of the Jahn-Teller effect theory and applications to molecular problems.

  2001cited by this paper
• EXAFS analysis using FEFF and FEFFIT.

  2001cited by this paper
• Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits*

  2001cited by this paper
• DFT Calculations for Cu-, Ag-, and Au-Containing Molecules

  2001cited by this paper
• Copper(I) and Copper(II) Coordination Structure under Hydrothermal Conditions at 325 °C: An X-ray Absorption Fine Structure and Molecular Dynamics Study

  2000cited by this paper
• Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

  2000cited by this paper
• MULTIPLE-SCATTERING X-RAY-ABSORPTION FINE-STRUCTURE DEBYE-WALLER FACTOR CALCULATIONS

  1999cited by this paper
• Estimation of uncertainties in XAFS data.

  1999cited by this paper
• Estimation of measurement uncertainties in XAFS data

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper
• Charge density-dependent strength of hydration and biological structure.

  1997cited by this paper
• Modulation of a salt link does not affect binding of phosphate to its specific active transport receptor.

  1996cited by this paper
• Multiple-scattering calculations of x-ray-absorption spectra.

  1995cited by this paper
• Density-functional thermochemistry. III. The role of exact exchange

  1993cited by this paper
• Near-edge x-ray-absorption fine structure of Pb: A comparison of theory and experiment.

  1993cited by this paper
• Constrained and Restrained Refinement in EXAFS Data Analysis with Curved Wave Theory

  1992cited by this paper
• Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement

  1991cited by this paper
• Copper K-extended x-ray absorption fine structure studies of oxidized and reduced dopamine beta-hydroxylase. Confirmation of a sulfur ligand to copper(I) in the reduced enzyme.

  1991cited by this paper
• An understanding of the X-ray absorption near-edge structure of copper(II) imidazole complexes

  1990cited by this paper
• Electron spin resonance and electronic spectra and crystal and molecular structures of copper(II) amino acid complexes

  1987cited by this paper
• X-ray absorption edge determination of the oxidation state and coordination number of copper: application to the type 3 site in Rhus vernicifera laccase and its reaction with oxygen

  1987cited by this paper
• Ab initio effective core potentials for molecular calculations

  1984cited by this paper
• Geometry optimization by direct inversion in the iterative subspace

  1984cited by this paper
• Relativistic Calculation of Anomalous Scattering Factors for X Rays

  1970cited by this paper

• Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

  2025cites this paper
• Identifying the important involvement of cuproptosis in the pathophysiology of age-related macular degeneration

  2025cites this paper
• A metabolic perspective on cuproptosis.

  2025cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease

  2024cites this paper
• Nanostructure and dynamics of N-truncated copper amyloid-β peptides from advanced X-ray absorption fine structure

  2024cites this paper
• Probing the Dynamic Landscape: from Static to Time-Resolved X-ray Absorption Spectroscopy to Investigate Copper Redox Chemistry in Neurodegenerative Disorders.

  2024cites this paper
• Using XAS to monitor radiation damage in real time and post-analysis, and investigation of systematic errors of fluorescence XAS for Cu-bound amyloid-β

  2024cites this paper
• Copper-dependent cell death (cuproptosis): perspectives for pharmacological correction in human diseases

  2024cites this paper
• Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective.

  2024cites this paper
• Investigating Anion Effects on Metal Ion Binding Interactions With Amyloid β Peptide by Ion Mobility Mass Spectrometry.

  2024cites this paper
• Degradation of Amyloid-β Species by Multi-Copper Oxidases

  2024cites this paper
• An Electrochemistry and Computational Study at an Electrified Liquid–Liquid Interface for Studying Beta-Amyloid Aggregation

  2023cites this paper
• The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.

  2023cites this paper
• Copper Accumulation and the Effect of Chelation Treatment on Copper Accumulation and the Effect of Chelation Treatment on Cerebral Amyloid Angiopathy Compared to Parenchymal Amyloid Cerebral Amyloid Angiopathy Compared to Parenchymal Amyloid Plaques Plaques

  2023cites this paper
• Degradation of amyloid beta species by multi-copper oxidases

  2023cites this paper
• Cu(Proline)2 Complex: A Model of Bio-Copper Structural Ambivalence

  2022cites this paper
• Role of Alginate Composition on Copper Ion Uptake in the Presence of Histidine or Beta-Amyloid

  2022cites this paper
• Copper homeostasis and cuproptosis in health and disease

  2022cites this paper
• Insights from Self-Assembled Aggregates of Amyloid β Peptides on Gold Surfaces

  2022cites this paper
• Potential molecular and graphene oxide chelators to dissolve amyloid-β plaques in Alzheimer's disease: a density functional theory study.

  2021cites this paper
• Redox state and photoreduction control using X-ray spectroelectrochemical techniques - advances in design and fabrication through additive engineering.

  2021cites this paper
• Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

  2021cites this paper
• Amyloid-beta–copper interaction studied by simultaneous nitrogen K and copper L2,3-edge soft X-ray absorption spectroscopy

  2021influential citation
• Salpyran: A Cu(II) Selective Chelator with Therapeutic Potential.

  2021cites this paper
• Investigation of bovine serum albumin aggregation upon exposure to silver(i) and copper(ii) metal ions using Zetasizer

  2021cites this paper
• Another pearl in the "copper-transport" necklace.

  2021cites this paper
• Forcefield evaluation and accelerated molecular dynamics simulation of Zn(II) binding to N-terminus of amyloid-β

  2021cites this paper
• Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology

  2020cites this paper
• Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

  2020cites this paper
• Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.

  2020cites this paper
• “What Doesn’t Kill You Makes You Stronger”: Future Applications of Amyloid Aggregates in Biomedicine

  2020cites this paper
• Active-site environment of Cu bound amyloid β and amylin peptides

  2019cites this paper
• X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.

  2019cites this paper
• Effects of Metal Ions on Aβ42 Peptide Conformations from Molecular Simulation Studies

  2019cites this paper
• The investigation of 2D monolayers as potential chelation agents in Alzheimer’s disease

  2019cites this paper
• Molecular dynamics simulations of copper binding to amyloid-β Glu22 mutants

  2019cites this paper
• The investigation of 2D monolayers as potential chelation agents in Alzheimer’s disease

  2019cites this paper
• Replica exchange molecular dynamics simulation of the coordination of Pt(ii)-Phenanthroline to amyloid-β

  2019cites this paper
• Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

  2019cites this paper
• Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies

  2019cites this paper
• Dealing with Cu reduction in X-ray absorption spectroscopy experiments.

  2019cites this paper
• Metal Binding to Amyloid-β1-42: A Ligand Field Molecular Dynamics Study.

  2018cites this paper
• Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals

  2018cites this paper
• Benchmarking of copper(II) LFMM parameters for studying amyloid-β peptides

  2018cites this paper
• Structural Insight into Redox Dynamics of Copper Bound N-Truncated Amyloid-β Peptides from in Situ X-ray Absorption Spectroscopy.

  2018cites this paper
• Metal Binding to Aβ Peptides Inhibits Interaction with Cytochrome c: Insights from Abiological Constructs

  2018cites this paper
• Revisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries

  2018cites this paper
• The double-edged role of copper in the fate of amyloid beta in the presence of anti-oxidants† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc01787a Click here for additional data file.

  2017cites this paper
• Conformational Transitions of the Amyloid‐β Peptide Upon Copper(II) Binding and pH Changes

  2017cites this paper
• Alzheimer’s disease: How metal ions define β-amyloid function

  2017cites this paper
• Effect of Phase Separated Sericin on the Gelation Behavior of Silk Fibroin

  2016cites this paper
• Identification of different coordination geometries by XAFS in copper(II) complexes with trimesic acid

  2016cites this paper
• Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer’s Drug Discovery

  2016cites this paper
• Challenges in studying the structures of metal-amyloid oligomers related to type 2 diabetes, Parkinson's disease, and Alzheimer's disease

  2016cites this paper
• Probing oligomerization of amyloid beta peptide in silico.

  2016cites this paper
• Iron, aging, and neurodegeneration

  2015cites this paper
• Development and Application of a Nonbonded Cu2+ Model That Includes the Jahn–Teller Effect

  2015cites this paper
• A first-principle calculation of the XANES spectrum of Cu(2+) in water.

  2015cites this paper
• Development and Application of a Nonbonded Cu 2 + Model That Includes the Jahn − Teller E ff ect

  2015cites this paper
• Redesign of calcium-regulated protein aequorin towards the development of a novel ion bioreporter

  2014cites this paper
• Insights into the oxygen-based ligand of the low pH component of the Cu(2+)-amyloid-β complex.

  2014cites this paper
• Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of Aβ-peptide associated with Alzheimer's disease.

  2014cites this paper
• 3D structures and redox potentials of Cu2+-Aβ(1-16) complexes at different pH: a computational study.

  2014cites this paper
• New force field parameters for metalloproteins I: Divalent copper ion centers including three histidine residues and an oxygen‐ligated amino acid residue

  2014cites this paper
• Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.

  2013cites this paper
• Interaction of amyloid β peptides with redox active heme cofactor: Relevance to Alzheimer's disease

  2013cites this paper
• Amyloid-β peptide active site: theoretical Cu K-edge XANES study

  2013cites this paper
• Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration

  2013cites this paper
• The Role of Aβ in Alzheimer's Disease

  2013cites this paper
• Structural studies of the tethered N‐terminus of the Alzheimer's disease amyloid‐β peptide

  2013cites this paper
• Ligand-field and ligand-binding analysis of the active site of copper-bound Aβ associated with Alzheimer's disease.

  2013cites this paper
• Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide.

  2013cites this paper
• Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro.

  2012cites this paper
• Methods and techniques to study the bioinorganic chemistry of metal–peptide complexes linked to neurodegenerative diseases

  2012cites this paper
• Copper and oxidative stress in the pathogenesis of Alzheimer's disease.

  2012cites this paper
• Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 1: An overview

  2012cites this paper
• Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-β peptides involved in Alzheimer disease. Part 2: Dependence of Cu(II) binding sites with Aβ sequences

  2012cites this paper
• The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.

  2012cites this paper
• Metal binding sites in amyloid oligomers: Complexes and mechanisms

  2012cites this paper
• Nanoprobing of the Effect of Cu2+ Cations on Misfolding, Interaction and Aggregation of Amyloid β Peptide

  2012cites this paper
• Label-free electrochemical detection of Amyloid beta aggregation in the presence of iron, copper and zinc

  2012cites this paper
• Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

  2012cites this paper
• Label-free methods for probing the interaction of clioquinol with amyloid-β

  2012cites this paper
• Structural and Computational Studies of Interactions of Metals with Amyloid Beta

  2012cites this paper
• Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases

  2012cites this paper
• Molecular Modeling of the Amyloid β-Peptide: Understanding the Mechanism of Alzheimer's Disease and the Potential for Therapeutic Intervention

  2012cites this paper
• The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.

  2011cites this paper
• X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties.

  2011cites this paper
• Three dimensional models of Cu(2+)-Aβ(1-16) complexes from computational approaches.

  2011cites this paper
• Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.

  2011cites this paper
• Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

  2011cites this paper
• Aggregation of amyloids in a cellular context: modelling and experiment.

  2011cites this paper
• Crystal Structure of the Amyloid-β p3 Fragment Provides a Model for Oligomer Formation in Alzheimer's Disease

  2011cites this paper
• The chemical process of oxidative stress by copper(II) and iron(III) ions in several neurodegenerative disorders

  2011cites this paper
• Ab initio design of chelating ligands relevant to Alzheimer's disease: influence of metalloaromaticity.

  2011cites this paper
• CrystalStructureoftheAmyloid-p3FragmentProvidesa ModelforOligomerFormationinAlzheimer'sDisease

  2011cites this paper
• NMR Studies of Zinc, Copper, and Iron Binding to Histidine, the Principal Metal Ion Complexing Site of Amyloid-β Peptide

  2010cites this paper
• On the metal ion (Zn2+, Cu2+) coordination with beta-amyloid peptide: DFT computational study

  2010cites this paper
• Generation of soluble oligomeric β-amyloid species via copper catalyzed oxidation with implications for Alzheimer’s disease: A DFT study

  2010cites this paper